Cancer

At the Kolling Institute, our cancer research aims to identify and overcome the factors that drive cancer development so that we can improve patient outcomes. We have a number of cancer research teams with different expertise, specialising in chemotherapy resistance, immunotherapies, genetics, epigenetics, diagnostic services and clinical trials. Importantly, these teams have access to an active tissue bank and the latest equipment.

Our cancer research rapidly implements laboratory findings into clinical practice and is supported by the Cancer Institute Translational Centre, Sydney Vital. By bringing together research scientists, clinicians and allied health professionals, we are able to combine innovative and cutting edge research with personalised treatment strategies for cancer patients.

Find out more about:

Bill Walsh Translational Cancer Research Laboratory

Bowel Cancer and Biomarker Research Lab

Breast Cancer Research

Cancer Genetics Laboratory

Kolling Institute Tumour Bank

Events, News and Seminars

Celebrating the quiet achievers behind our clinical trial success

Celebrating the quiet achievers behind our clinical trial success

International Clinical Trials Day provided the chance to recognise the many people contributing to o..... Read more

Category: New Treatment, Research Excellence

Kolling Institute Newsletter May 2025
Multi-million dollar grant to improve treatment for lung cancer

Multi-million dollar grant to improve treatment for lung cancer

Leading Royal North Shore Hospital clinician researcher Professor Nick Pavlakis and Professor Ben So..... Read more

Category: Funding support, Research Excellence